Tag: biosimilars and US tariffs

The global pharmaceutical industry is facing a major shake-up after U.S. President Donald Trump announced a 100% tariff on all imported branded and patented drugs. This bold move, effective from October 1, 2025, is intended to push multinational pharmaceutical giants to manufacture within the U.S. borders. While Indian generic medicines have been spared from this…